Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Merit Medical Systems | MMSI | Jan 29, 2025 | 108.48 | -0.50 |
Meritage Homes | MTH | Jan 29, 2025 | 78.82 | -2.55 |
Merrill Lynch & Co. | IPB | Jan 29, 2025 | 26.00 | 0.00 |
Mersana Therapeutics | MRSN | Jan 29, 2025 | 0.59 | -9.34 |
Merus N.V | MRUS | Jan 29, 2025 | 41.65 | +2.33 |
Mesa Air Group | MESA | Jan 29, 2025 | 1.25 | 0.00 |
Mesa Laboratories | MLAB | Jan 29, 2025 | 136.72 | -1.92 |
Mesa Royalty Trust | MTR | Jan 29, 2025 | 7.05 | -3.03 |
Mesabi Royalty Trust | MSB | Jan 29, 2025 | 33.83 | -2.68 |
Mesoblast ADR | MESO | Jan 29, 2025 | 19.55 | +6.71 |
Meta Platforms A | META | Jan 29, 2025 | 676.49 | +0.32 |
Metagenomi | MGX | Jan 29, 2025 | 2.65 | -3.99 |
Metal Sky Star Acquisition | MSSA | Jan 29, 2025 | 11.80 | 0.00 |
Metalla Royalty & Streaming | MTA | Jan 29, 2025 | 2.78 | +1.46 |
Metallus | MTUS | Jan 29, 2025 | 15.25 | +0.93 |
MetaVia | MTVA | Jan 29, 2025 | 1.89 | 0.00 |
Methalpa Technology Holding | MATH | Jan 29, 2025 | 1.58 | -4.53 |
Methanex | MEOH | Jan 29, 2025 | 49.85 | +1.65 |
Methode Electronics | MEI | Jan 29, 2025 | 11.64 | -0.77 |
MetLife | MET | Jan 29, 2025 | 86.64 | +1.12 |
Metlife Pref A | MET-A | Jan 29, 2025 | 25.15 | 0.00 |
Metlife Pref E | MET-E | Jan 29, 2025 | 24.39 | -0.45 |
Metlife Pref F | MET-F | Jan 29, 2025 | 21.24 | -0.75 |
MetroCity Bankshares | MCBS | Jan 29, 2025 | 31.39 | -0.57 |
Metropolitan Bank | MCB | Jan 29, 2025 | 64.17 | -0.76 |
Mettler-Toledo International | MTD | Jan 29, 2025 | 1 335.50 | -1.28 |
Mexco Energy | MXC | Jan 29, 2025 | 11.56 | -2.05 |
Mexico Equity And Income Fund | MXE | Jan 29, 2025 | 8.39 | -0.24 |
Mexico Fund | MXF | Jan 29, 2025 | 13.73 | -0.07 |
Mexico Investable Mkt Idx MSCI Ishares | EWW | Jan 29, 2025 | 49.76 | +0.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.